Charles Hillier
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles Hillier has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alison Nock
Dorset MS Service, Poole Hospital NHS Foundation Trust, Poole BH15 2JB, UK
2 shared publications - Kathleen Galvin
University of Brighton
2 shared publications - Peter Thomas
Bournemouth University
2 shared publications - Roger Baker
Clinical Research Unit, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK
2 shared publications - Rosemary Jones
MS Research Unit, Bristol & Avon Multiple Sclerosis (BrAMS) Centre, Southmead Hospital, Southmead Road, Bristol, BS10 5NB, UK
2 shared publications - Sarah Thomas
Clinical Research Unit, Faculty of Health and Social Sciences, Bournemouth University, Bournemouth, UK
2 shared publications
Latest Publications
- Open Access
- 19 May 2014
- Published by Springer Nature in BMC Neurology
- Vol. 14 (1) , 109
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Fatigue is one of the most common and debilitating symptoms of multiple sclerosis (MS). The aim was to evaluate the effectiveness at 1-year follow-up of a manualised group-based programme (‘FACETS’) for managing MS-fatigue.
- 19 May 2014
- Published by Springer Nature in BMC Neurology
- Vol. 14 (1) , 109
Open AccessOne year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis
Fatigue is one of the most common and debilitating symptoms of multiple sclerosis (MS). The aim was to evaluate the effectiveness at 1-year follow-up of a manualised group-based programme (‘FACETS’) for managing MS-fatigue.
- Open Access
- 16 June 2010
- Published by Springer Nature in BMC Neurology
- Vol. 10 (1) , 43
Multi-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis
Fatigue is one of the most commonly reported and debilitating symptoms of multiple sclerosis (MS); approximately two-thirds of people with MS consider it to be one of their three most troubling symptoms. It may limit or prevent participation in everyday activities, work, leisure, and social pursuits, reduce psychological well-being and is one of the key precipitants of early retirement. Energy effectiveness approaches have been shown to be effective in reducing MS-fatigue, increasing self-efficacy and improving quality of life. Cognitive behavioural approaches have been found to be effective for managing fatigue in other conditions, such as chronic fatigue syndrome, and more recently, in MS. The aim of this pragmatic trial is to evaluate the clinical and cost-effectiveness of a recently developed group-based fatigue management intervention (that blends cognitive behavioural and energy effectiveness approaches) compared with current local practice.
- 16 June 2010
- Published by Springer Nature in BMC Neurology
- Vol. 10 (1) , 43
Open AccessMulti-centre parallel arm randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based cognitive behavioural approach to managing fatigue in people with multiple sclerosis
Fatigue is one of the most commonly reported and debilitating symptoms of multiple sclerosis (MS); approximately two-thirds of people with MS consider it to be one of their three most troubling symptoms. It may limit or prevent participation in everyday activities, work, leisure, and social pursuits, reduce psychological well-being and is one of the key precipitants of early retirement. Energy effectiveness approaches have been shown to be effective in reducing MS-fatigue, increasing self-efficacy and improving quality of life. Cognitive behavioural approaches have been found to be effective for managing fatigue in other conditions, such as chronic fatigue syndrome, and more recently, in MS. The aim of this pragmatic trial is to evaluate the clinical and cost-effectiveness of a recently developed group-based fatigue management intervention (that blends cognitive behavioural and energy effectiveness approaches) compared with current local practice.